235 related articles for article (PubMed ID: 2439185)
1. Chemotherapy of disseminated germ cell tumors.
Einhorn LH
Cancer; 1987 Aug; 60(3 Suppl):570-3. PubMed ID: 2439185
[TBL] [Abstract][Full Text] [Related]
2. Treatment of testicular cancer: a new and improved model.
Einhorn LH
J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.
Einhorn LH; Williams SD; Loehrer PJ; Birch R; Drasga R; Omura G; Greco FA
J Clin Oncol; 1989 Mar; 7(3):387-91. PubMed ID: 2465391
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for favorable outcome in disseminated germ cell tumors.
Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
[TBL] [Abstract][Full Text] [Related]
6. Treatment strategies of testicular cancer in the United States.
Einhorn LH
Int J Androl; 1987 Feb; 10(1):399-405. PubMed ID: 2438232
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up.
Roth BJ; Greist A; Kubilis PS; Williams SD; Einhorn LH
J Clin Oncol; 1988 Aug; 6(8):1239-47. PubMed ID: 2457658
[TBL] [Abstract][Full Text] [Related]
9. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.
Germá JR; Sagarra AF; Izquierdo MA; Seguí MA
Cancer; 1993 Feb; 71(3):796-803. PubMed ID: 7679314
[TBL] [Abstract][Full Text] [Related]
10. Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study.
Samson MK; Rivkin SE; Jones SE; Costanzi JJ; LoBuglio AF; Stephens RL; Gehan EA; Cummings GD
Cancer; 1984 Mar; 53(5):1029-35. PubMed ID: 6198064
[TBL] [Abstract][Full Text] [Related]
11. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
12. [VP-16 salvage therapy of PVB regimen-resistant testicular germ cell tumors].
Yamazaki H; Yuichiro A; Kondo N; Imanaka K; Machida T
Nihon Hinyokika Gakkai Zasshi; 1987 Jul; 78(7):1227-31. PubMed ID: 2446041
[No Abstract] [Full Text] [Related]
13. A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
Fizazi K; Do KA; Wang X; Finn L; Logothetis CJ; Amato RJ
Ann Oncol; 2002 Jan; 13(1):125-34. PubMed ID: 11863094
[TBL] [Abstract][Full Text] [Related]
14. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.
Levi JA; Raghavan D; Harvey V; Thompson D; Sandeman T; Gill G; Stuart-Harris R; Snyder R; Byrne M; Kerestes Z
J Clin Oncol; 1993 Jul; 11(7):1300-5. PubMed ID: 7686216
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of chemotherapy by the AVM protocol (adriamycin, vincristine and methotrexate) after unsuccessful treatment of patients with non-seminoma using PVB (cisplatin, vinblastine and bleomycin)].
Madej G; Siedlecki P; Pieńkowski T
Nowotwory; 1984; 34(4):329-34. PubMed ID: 6085587
[No Abstract] [Full Text] [Related]
18. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L
Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779
[TBL] [Abstract][Full Text] [Related]
19. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
20. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.
Williams SD; Birch R; Einhorn LH; Irwin L; Greco FA; Loehrer PJ
N Engl J Med; 1987 Jun; 316(23):1435-40. PubMed ID: 2437455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
